Blepharitis
📧 Sign up to get email alerts when something new happens for Blepharitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine [Phase 4]
Phase 4 trial evaluating eyelid cleansing with wipes containing topical chlorhexidine for blepharitis caused by Demodex folliculorum has com…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment [NA]
This is a clinical trial update for IRIDIUM GARZE as adjuvant therapy for blepharitis and blepharoconjunctivitis. The study is currently rec…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Photobiomodulation With REd vs BluE Light (REBEL) [NA]
A recruiting Aston University trial compares red versus blue light photobiomodulation for dry eye conditions, including meibomian gland dysf…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment [Phase 3]
Phase 3 trial evaluating Pimecrolimus 0.3% ophthalmic ointment for blepharitis has been terminated.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis. [Phase 2]
Phase 2, multicenter, randomized, double-blind study assessing the efficacy and safety of APT-001 (Spinosad 1.8%) topical therapy for blepha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD [Phase 2]
Phase 2 pilot trial comparing two dosing regimens of TP-03 for Meibomian Gland Dysfunction and Blepharitis (with Demodex infestation); safet…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation [Phase 4]
Phase 4 clinical trial evaluating the safety and efficacy of Moxidectin tablets to reduce Demodex eyelash infestation has been completed. Th…
-
FDA approval · 2025-04-07FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)
Supplemental FDA approval for tobramycin and dexamethasone (Sandoz) as an ophthalmic combination product.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction
A completed trial comparing continuous versus pulsed oral doxycycline regimens in refractory meibomian gland dysfunction (with blepharitis).
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study [Phase 3]
Phase 3 trial evaluating the efficacy and safety of TP-03 (LIBRA Study) in blepharitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex [Phase 2]
Phase 2 clinical trial investigating the effects of an exploratory vehicle on Meibomian Gland Dysfunction associated with Demodex infestatio…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis [Phase 3]
Phase 3 trial for TP-03 in treating Demodex blepharitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis [Phase 2, Phase 3]
Phase 2/3 trial results for TP-03 in blepharitis have been completed with results posted in late 2023.
-
FDA approval · 2023-07-24FDA Approved: XDEMVY — Original Application (Tarsus Pharmaceuticals, Inc.)
FDA approved XDEMVY (lotilaner ophthalmic solution) from Tarsus Pharmaceuticals for the treatment of Demodex blepharitis.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis [Phase 2]
Phase 2 trial evaluating safety and tolerability of NCX 4251 for acute exacerbations of blepharitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of NCX 4251 ophthalmic suspension for blepharitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis [Phase 3]
Phase 3 trial report on a steroid/antibiotic eyedrop for blepharitis assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% [Phase 3]
Phase 3 trial evaluating ivermectin gel 0.1% plus metronidazole 1% for chronic blepharitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects [Phase 3]
Phase 3 trial comparing ISV-305 to vehicle in active, symptomatic blepharitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease [Phase 2]
Phase 2 clinical trial update on KPI-121 for inflammatory Meibomian Gland Disease (blepharitis) completed with results posted.
-
FDA approval · 2019-04-19FDA Approved: TOBRAMYCIN OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Tobramycin Ophthalmic Solution from Alembic Pharmaceuticals Inc. under an original generic application (ANDA).
-
CLINICAL_TRIALS research · 2018-05-14Clinical Trial Update: Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery [NA]
Clinical trial update on treating meibomian gland dysfunction before cataract surgery; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis [Phase 4]
Phase 4 clinical trial update evaluating a combination of Permethrin 5%, Fusidic Acid 1%, and Synthomycine 5% for Demodex-related blephariti…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Lipids of the Human Tear Film and Their Effect on Tear Stability [Phase 4]
Phase 4 clinical trial investigating how lipids in the human tear film affect tear stability in blepharitis has completed with results poste…
-
FDA approval · 2017-12-18FDA Approved: MAXITROL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for MAXITROL (neomycin sulfate, polymyxin B sulfate and dexamethasone) from Novartis Pharmaceuticals…